Xerox Corporation (NYSE:XRX) shares moved down -1.76% in last trading session and ended the day at $11.17. XRX Gross Margin is 32.60% and its return on assets is 4.20%. Xerox Corporation (NYSE:XRX) quarterly performance is -11.91%. Xerox Corp (NYSE:XRX) has received a “BBB-” credit rating from Morningstar. The research firm’s “BBB-” rating indicates that the company is a moderate default risk. They also gave their stock a three star rating.
On 12 June, Baker Hughes Incorporated (NYSE:BHI) shares moved down -0.42% and was closed at $64.13. BHI EPS growth in last 5 year was 23.80%. Baker Hughes Incorporated (NYSE:BHI) year to date (YTD) performance is 14.99%. Baker Hughes Incorporated (NYSE:BHI) announced that it is scheduled to issue a news release, detailing operational performance and earnings for the second quarter of 2015, before the market opens on Tuesday, July 21, 2015.
W.W. Grainger, Inc. (NYSE:GWW) belongs to Services sector. Its net profit margin is 10.00% and weekly performance is -1.22%. On last trading day company shares ended up $238.15. W.W. Grainger, Inc. (NYSE:GWW) distance from 50-day simple moving average (SMA50) is -1.74%. On June 12, Grainger (NYSE:GWW) reported sales results for the month of May 2015. Daily sales were flat versus May 2014. Results for the month included 1 percentage point from acquisitions and a 3 percentage point decline from unfavorable foreign exchange. Excluding acquisitions and foreign exchange, organic sales increased 2 percent driven by 3 percentage points from volume, partially offset by a 1 percentage point decline in price.
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) shares moved down -0.24% in last trading session and ended the day at $93.93. LGND Gross Margin is 87.70% and its return on assets is 5.70%. Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) quarterly performance is 25.26%. Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) announces that the FDA has approved a supplemental New Drug Application (sNDA) for the use of Promacta® (eltrombopag), a Novartis product, for the treatment of children six years and older with chronic immune thrombocytopenia (cITP) who have had an insufficient response to corticosteroids, immunoglobulins or splenectomy. Promacta was approved by the FDA in 2008 for use in adult patients with the same condition
Equity LifeStyle Properties, Inc. (NYSE:ELS) shares increased 0.06% in last trading session and ended the day at $53.03. ELS Gross Margin is 52.20% and its return on assets is 3.10%. Equity LifeStyle Properties, Inc. (NYSE:ELS) quarterly performance is -2.24%. The Board of Directors of Equity LifeStyle Properties, Inc. (NYSE:ELS) declared a dividend of $0.375 per common share, representing, on an annualized basis, a dividend of $1.50 per common share. The dividend will be paid on July 10, 2015 to stockholders of record on June 26, 2015.